Infection and Vaccine-Induced Neutralizing-Antibody Responses to the SARS-CoV-2 B.1.617 Variants
Venkata-Viswanadh Edara(Emory University), Benjamin A. Pinsky(Stanford University), Mehul S. Suthar(Emory University), Lilin Lai(Emory University), Meredith E. Davis-Gardner(Emory University), Katharine Floyd(Emory University), Maria W. Flowers(Emory University), Jens Wrammert(Emory University), Laila Hussaini(Emory University), Caroline Ciric(Emory University), Sarah Bechnak(Emory University), Kathy Stephens(Emory University), Barney S. Graham(National Institute of Allergy and Infectious Diseases), Elham Bayat Mokhtari(National Institute of Allergy and Infectious Diseases), Prakriti Mudvari(National Institute of Allergy and Infectious Diseases), Eli Boritz(National Institute of Allergy and Infectious Diseases), Adrian Creanga(National Institute of Allergy and Infectious Diseases), Amarendra Pegu(National Institute of Allergy and Infectious Diseases), Alexandrine Derrien-Colemyn(National Institute of Allergy and Infectious Diseases), Amy R. Henry(National Institute of Allergy and Infectious Diseases), Matthew Gagné(National Institute of Allergy and Infectious Diseases), Daniel C. Douek(National Institute of Allergy and Infectious Diseases), Malaya K. Sahoo(Stanford University), Mamdouh Sibai(Stanford University), Daniel Solis(Stanford University), Richard J. Webby(St. Jude Children's Research Hospital), Trushar Jeevan(St. Jude Children's Research Hospital), Thomas Fabrizio(St. Jude Children's Research Hospital)
Cited by 361Open Access
Abstract
To assess infection and vaccine-Induced Neutralizing-Antibody activity against the SARS-CoV-2 B.1.617.1 (or kappa) and B.1.617.2 (or delta) variants.
Related Papers
No related papers found
Powered by citation graph analysis